UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 21, 2022
Accession Number:
0001493152-22-001483
Submission Type:
POS AM
CIK:
0000946644
Company Name:
AIM ImmunoTech Inc.
File Number:
333-226059